complement cascade on the endothelial cell membrane, leading to endothelial cell activation and damage, intravascular graft thrombosis, and vessel occlusion (7) .
The complement system is activated via three wellcharacterized pathwaysVthe classic, the alternative, and the lectin pathways. Each of them has its own mechanism of activation, resulting in activation of C3, followed by generation of the membrane attack complex (8) . In hyperacute rejection, xenoreactive antibody-mediated activation of the classic pathway is commonly accepted as the main complement activation pathway (9, 10) . By amplifying the generation of C3b, the alternative pathway also becomes critical in xenograft rejection. However, currently available data do not answer the question whether the lectin pathway may also be involved in the initiation of xenorejection.
The lectin pathway is initiated by interactions between mannose-binding lectin (MBL) and certain carbohydrate arrays (11) . MBL naturally exists in a complex with MBLassociated serine proteases (MASPs) (12, 13) . When MBL binds to a target, the MASPs are activated (14) and cleave their respective substratesVC4 and C2 for MASP2 and C3 and C2 for MASP1 (15) . Historically, the lectin pathway of complement activation is known as antibody-independent pathway. However, several studies using animal models of ischemia-reperfusion injury demonstrated that MBL also interacts with immune complexes to activate complement via the lectin pathway (16Y18). In addition, a recent in vitro study suggested that 20% of human serum IgM could bind to immobilized human MBL (19, 20) .
In a bypass activation pathway, MBL can directly activate C3 and the alternative pathway of complement, which are independent of C2 (21) . In addition, MBL binding to polymeric IgA induces the initiation of lectin pathway of complement activation (22) . Furthermore, myocardial and skeletal ischemia-reperfusion injury studies demonstrated that complement activation and resulting C3 deposition are mediated by IgM and MBL (23, 24) and independent of C1q and the classic pathway (24) . Taken together, these observations extend the idea that activation of the lectin pathway of complement may not be completely antibody independent.
Thus far, the role of the lectin pathway of complement has not been looked at in xenotransplantation. The present study was therefore focused on lectin pathway activation in pig-to-human xenotransplantation. In particular, we investigated the interaction of MBL and IgM in pig-to-human in vitro as well as ex vivo xenotransplantation models.
RESULTS

Complement Pathways Involved in Pig-to-Human Xenorejection In Vitro (PAEC Treated with NHS)
Deposition of C1q (classic pathway), MBL (lectin pathway), and factor Bb (alternative pathway) on porcine aortic endothelial cells (PAEC) was assessed by cell enzymelinked immunosorbent assay (ELISA). Wild-type (WT) PAEC exposed to 1:2 diluted normal human serum (NHS) showed deposition of IgM, C1q, MBL, factor Bb, C3b/c, C4b/c, and C5b-9 (Fig. 1A) . In addition, MBL, C3b/c, and C6 deposition was shown on PAEC treated with 1:10 diluted, MBL-deficient, or C1q-depleted serum or NHS (Fig. 1B) . Incubation of WT PAEC with MBL-deficient or C1q-depleted serum also led to expression of adhesion molecules (VCAM-1 and CD62E; Fig. 1C ) as well as PAEC cytotoxicity (Fig. 1D ).
Lectin Pathway Complement Activation In VitroVColocalization Analysis
Immunofluorescence (IF) staining was performed on WT PAEC treated with 1:10 diluted NHS for the colocalized deposition of MBL with complement proteins. Deposition of MBL on WT PAEC was colocalized with MASP2, C3b/c, C4b/c, and C6, suggesting activation of the lectin pathway in this xenotransplantation setting (Fig. 2) .
Quantitative colocalization analysis was performed by Manders' correlation coefficient (R m ) using z-stack confocal images and Imaris software version 7.2.3 (Bitplane). A total overlap of both fluorescent color channels, indicating a perfect three-dimensional colocalization, is indicated by ''R m =1,'' and no colocalization by ''R m =0.'' The Manders' correlation coefficient values were 0.93 for MBL-MASP2, 0.84 for MBLC3b/c, 0.86 for MBL-C4b/c, and 0.80 for MBL-C6, suggesting an important contribution of MBL for total complement deposition in this model.
Colocalization of IgM and MBL/MASP2 on WT PAEC
Colocalization of natural IgM with MBL and MASP2 was investigated on NHS-treated PAEC by confocal microscopy. Colocalized deposition of IgM with MBL and MASP2 was observed on PAEC (yellow staining) (Fig. 3) . Manders' colocalization analysis showed near-perfect IgM colocalization with MBL (R m =0.87) and MASP2 (R m =0.83).
IgM-Dependent MBL and Complement Deposition on WT PAEC
Binding of MBL to the major porcine xenoantigen Gal>1-3Gal on WT PAEC was assessed in anti-Gal immunoabsorbed and immunoglobulin-depleted (Ig-depleted) serum, respectively. Compared with NHS, reduced MBL deposition was observed on PAEC when incubated with anti-Gal immunoabsorbed NHS or Ig-depleted serum. Purified polyclonal human IgM was used to replete anti-Gal immunoabsorbed NHS and Ig-depleted serum, respectively, which resulted in dose-dependently increased deposition of MBL, C3b/c, and C6 on PAEC (Fig. 3C,D) . In addition, WT PAEC were treated with purified human polyclonal IgM followed by incubation with purified MBL protein, resulting in a dosedependently increased binding of purified MBL to PAEC (Fig. 3D) .
Complement Regulation by GalTKO/ hCD46 PAEC WT or >-galactosyl transferase knockout (GalTKO)/ hCD46 PAEC were treated with 1:10 diluted NHS and assessed for complement deposition as well as complementmediated PAEC activation and cytotoxicity. Absence of Gal epitopes and overexpression of hCD46 (Fig. 4) significantly reduced binding of IgM, C1q, MBL, and downstream complement proteins on GalTKO/hCD46 PAEC compared with WT (Fig. 4D ). This reduced complement activation on the genetically modified PAEC correlated well with reduced complement-mediated cytotoxicity (Fig. 4E ). These observations were also confirmed by IF/confocal microscopy using WT and GalTKO/hCD46 PAEC treated with 1:10 diluted NHS (Fig. 4F ).
Analysis of Lectin Pathway Complement Activation during Ex Vivo Pig Limb Xenoperfusion
Extracorporeal perfusion of WT porcine forelimbs with heparin anticoagulated human blood did not reveal signs of hyperacute rejection and lasted for at least 12 hr, after which it had to be terminated due to continuous small blood losses. Blood gas analysis showed constant physiologic potassium, lactate (10.78T0.63), and pH values (7.32T0.06). All limbs showed full muscular response on neural stimulation throughout the experiments. Stable and physiologic hemodynamic perfusion parameters (pressure, flow) could be maintained throughout all perfusions. To prevent blood loss due to bleeding, biopsy samples were collected only at later time points of perfusion, except for one experiment where samples were collected 1 hr after the onset of perfusion. These biopsy samples were used to analyze deposition of MBL, C1q, and factor Bb (Fig. 5AYC) .
Tissue samples taken after 12 hr perfusion were stained for deposition of human IgM, MBL, C3b/c, C4b/c, and C6. Analysis by fluorescence microscopy revealed that IgM, C3b/c, C4b/c, and C6 were codeposited with human MBL in the tissue. Quantitative two-dimensional colocalization analysis was performed by Pearson's correlation coefficient (R p ) using fluorescence microscopy images and Imaris software. A total overlap of both fluorescent color channels, represented as ''R p =+1,'' indicates a perfect colocalization, ''R p =0'' random colocalization, and ''R p =j1'' perfect exclusion. The R p values were 0.88 for IgM-MBL, 0.82 for C3b/c-MBL, 0.63 for C4b/c-MBL, and 0.81 for C6-MBL (Fig. 5DYS) .
DISCUSSION
The role of complement activation in the pathogenesis of pig-to-human xenograft rejection is well established. However, almost nothing is known to date about the activation of the lectin pathway of complement in xenorejection. We demonstrate here for the first time that all three pathways of complement are activated in a model of pig-to-human xenotransplantation. We could show full activation of complement, including formation of the terminal complement complex and complement-mediated cytotoxicity also in the absence of C1q. In addition, our data indicate that activation of the MBL route of complement is dependent on IgM, both in vitro and ex vivo, in a pig-to-human xenotransplantation model. Cell ELISA, activation of classic, lectin, and alternative complement pathways in a pig-to-human in vitro xenotransplantation model. A, WT PAEC were treated with 1:2 diluted NHS at 37-C for 45 min and the deposition of human IgM as well as complement proteins was assessed by specific antibodies. B, treatment of PAEC with 1:10 diluted NHS, MBL-deficient serum and C1q-depleted serum, respectively, and assessment of deposition of C1q, MBL, factor Bb, C3b/c, and C6. C, prolonged incubation (4 hr at 37-C) of PAEC with NHS/C1q-depleted serum/MBL-deficient serum (1:10) and assessment of the expression of adhesion molecules VCAM-1 and CD62E. D, treatment of PAEC with 1:10 diluted NHS/C1q-depleted serum/ MBL-deficient serum for 120 min at 37-C and assessment of cytotoxicity by calcein AM and EthD-1. Significance was tested using one-way calcein AM with Bonferroni correction (*PG0.05, **PG0.01, ***PG0.001). Data are meanTSD of three independent experiments.
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Endothelium is the first cell type to make contact with the recipients' blood in xenotransplantation or xenoperfusion. We therefore chose to analyze the effects of human serum on PAEC in vitro to perfuse porcine limbs ex vivo with whole, heparin-anticoagulated human blood. PAEC treated with NHS showed deposition of MBL, C1q, and factor Bb on their surface, indicating that all three pathways are involved in complement-mediated xenograft damage. In addition, deposition of C4b/c, C3b/c, C6, and C5b-9, detected as C9 neoepitope, were also observed on NHS-treated PAEC. The same markers, indicating full activation of complement, were also found when C1q-depleted serum was used. Furthermore, C1q-depleted serum induced PAEC activation, as measured by expression of the adhesion molecules E-selectin and VCAM-1, as well as PAEC cytotoxicity in a complement-dependent manner.
Binding of MBL was colocalized with C3b/c, C4b/c, and C6 on PAEC, suggesting that deposition of MBL on the cells plays a functional role in complement activation. Because natural antibodies are the major contributors to complement activation, the involvement of IgM in lectin pathway activation was then investigated. Colocalization studies on PAEC treated with NHS revealed that MBL/MASP2 deposition was colocalized with IgM, quantitative Manders' coefficient values indicating a near 100% colocalization, suggesting that IgM and MBL may work together in a synergetic way. The importance of anti-Gal IgM in lectin pathway activation was further confirmed by depletion of anti-Gal antibodies from NHS by immunoabsorption, which led to a significantly reduced binding of IgM as well as MBL on PAEC and also to a reduction of C5b-9 deposition. Repletion of immunoabsorbed or total Ig-depleted serum with polyclonal human IgM resulted in a dose-dependently increased deposition of IgM, MBL, and further downstream complement components. In addition, a dose-dependent deposition of purified MBL was found on PAEC treated with human polyclonal IgM. Taken together, these data indicate that the activation of the lectin pathway of complement in this xenotransplantation model is dependent on IgM binding to the target cells. This finding is in line with a recent study showing MBL binding sites on IgM, containing mainly GlcNActerminated glycans, which are strong ligands for MBL (20) . Also, the oligomannose structures present on IgM at Asn-402 and Asn-563 could provide binding sites for MBL (25, 26) .
Knockout of the Gal epitope in pigs is currently being combined with overexpression of human complement regulatory proteins such as hCD46 to prevent pig-to-human xenograft rejection. In this study, PAEC from GalTKO/hCD46 pigs showed significantly reduced deposition of MBL and complement proteins as well as no cytotoxicity when treated with NHS. These observations suggest that GalTKO and expression hCD46 could also help to prevent lectin pathway activation during pig-to-human xenotransplantation.
Tissue samples from porcine forelimbs ex vivo xenoperfused with whole, heparin-anticoagulated human blood were analyzed for the involvement of IgM-mediated lectin pathway activation. Deposition of MBL, C1q, and factor Bb was observed on 1 hr perfusion samples, suggesting that all three pathways of complement are activated. In addition, MBL was colocalized with IgM in 12 hr perfusion samples and the finding of colocalized deposition of MBL with C3, C4, and C6 indicates that also in ex vivo xenoperfusion the MBL route of complement is functional, confirming the in vitro data.
In conclusion, our results demonstrate activation and pathogenic role of the lectin pathway of complement in xenotransplantation. Colocalized deposition of IgM with MBL and MASP2 indicates that activation of the lectin pathway of complement in this pig-to-human xenotransplantation model is dependent on IgM.
MATERIALS AND METHODS
Cell ELISA and Determination of Complement Activation Pathways in Xenotransplantation
A modified whole-cell ELISA was used to detect the complement pathways involved in xenotransplantation, similar to methods described previously (27, 28) . WT PAEC as well as GalTKO/hCD46 transgenic PAEC were grown to confluence in 96-well plates and washed twice with ELISA wash buffer supplemented with or without calcium (45 mM NaCl, 10 mM HEPES, 680 mM CaCl 2 , and 490 mM MgCl 2 ). Pooled NHS or alternatively C1q-depleted serum (A509; Quidel, Darmstadt, Germany) or MBL-deficient serum (HSR002; Statens Serum Institut, Copenhagen, Denmark) in GVB ++ (1:2 or 1:10) was added to the cells and incubated at 37-C followed by washing with ELISA wash buffer. Cells were fixed in 1% paraformaldehyde for 15 min at room temperature (RT), washed, and blocked with phosphate-buffered saline (PBS)/1% bovine serum albumin (BSA) for 90 min at RT. Goat antihuman IgM (fluorescein isothiocyanate [FITC] labeled; catalog number F5384; Dako, Carpinteria, CA), rabbit anti-human C1q (A0136; Dako), mouse anti-human MBL (clone 15C5; sc80598; Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-human factor Bb (ab72658; Abcam, Cambridge, UK), rabbit anti-human C3b/c (FITC labeled; A0062; Dako), rabbit anti-human C4b/c (FITC labeled; F0169; Dako), mouse anti-human C5b-9 (aE11; 5010; Diatec, Oslo, Norway), mouse anti-human CD62E (LS-C13922; LifeSpan, * 2013 Lippincott Williams & Wilkins were adopted. Briefly, confluent WT and GalTKO/hCD46 PAEC in a 96-well plate were exposed to 1:10 diluted NHS, C1q-depleted or MBL-deficient serum, for 120 min at 37-C. After washing with PBS, 100 KL of 1 KM calcein AM and 2 KM EthD-1 was added to the cells and incubated in dark for 15 min. The fluorescence excitation and emissions of calcein AM and EthD-1 were acquired at 485/535 and 530/635 nm, respectively, using the Infinite M1000 microplate reader (Tecan) .
IF Staining
Activation of the lectin pathway of complement was further investigated by immunofluorescence staining using confocal microscopy. Briefly, WT PBS/1% BSA were incubated for 60 min and the slides were mounted with glycergel (C0563; Dako). The stained slides were then analyzed using a Zeiss LSM5 confocal laser scanning microscope.
Immunoabsorption of Human Serum on PAA-Bdi Sepharose
To investigate the importance of anti-Gal>1-3Gal IgM for MBL binding to PAEC, immunoabsorption of NHS was carried out to eliminate anti-Gal antibodies from NHS. Conjugates of the B-disaccharide Gal>1-3Gal (Bdi) and poly-N-hydroxyethylacrylamide (PAA-Bdi), covalently linked to Sepharose 6FF (PAA-Bdi Sepharose), were obtained from Dr. Nicolai Bovin (Moscow, Russia). Mini-spin columns were packed with 100 or 200 KL PAA-Bdi Sepharose and rinsed with PBS (10Y15 min, 200 rpm, 0-C). NHS (450 KL) was absorbed over the columns. Thereafter, immunoabsorbed NHS aliquots were prepared and stored at j80-C until use.
Role of IgM on MBL Binding to PAEC
The influence of IgM on binding of MBL to PAEC was investigated by cell ELISA using immunoabsorbed NHS and Ig-depleted serum (SunnyLab, Kent, UK). Human polyclonal IgM (A50168H; Meridian Life Science, Cincinnati, OH) was used to replete immunoabsorbed NHS/Ig-depleted serum. Binding of purified MBL (HSR008; Statens Serum Institut) on PAEC in the presence of human polyclonal IgM was also tested.
Ex vivo Xenoperfusion of Pig Limbs with Whole, Anticoagulated Human Blood
Six forelimbs of WT pigs were used to perfuse with whole, heparinanticoagulated human blood (29, 30) . Large white pigs were premedicated and anesthetized with ketamine, xylazine, midazolam, and atropine and mechanically ventilated (O 2 /air 1:3, isoflurane 1Y1.5 vol.%). Forelimbs were amputated by dissection of the shoulder girdle muscles using an electrocautery device (ICC 350; ERBE Elektromedizin, Tübingen, Germany). The neurovascular bundle in the axillar region was laid open and two veins and one artery of the amputated forelimb were cannulated using 10 French cannulas. All animal experiments were conducted in compliance with the Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, revised 1996) and Swiss national guidelines. The study was approved by the local animal experimentation committee of the Canton of Bern.
Five hundred milliliters of blood each were withdrawn from individual human donors into standard transfusion bags to which 10,000 IU heparin were added. The porcine forelimbs were attached to extracorporeal perfusion circuits as described previously (29) . Xenogeneic perfusion of the porcine limbs was then performed with the whole, heparin-anticoagulated human blood. The perfusion parameters (arterial blood gas, response to nerve stimulation, etc.) were monitored throughout the experiment.
Skeletal muscle biopsies were collected before perfusion from the contralateral extremity as baseline samples. Different time-point biopsies were collected after 1 hr (n=1) and 12 hr (n=6) of perfusions. Samples were fixed in 2% buffered formaldehyde solution for 24 hr and then transferred into 18% sucrose for 15 hr. Then, the samples were embedded in Shandon M1 embedding matrix (Thermo Scientific, Waltham, MA) and stored at j20-C until sectioned.
IF Staining for IgM-Dependent Lectin Pathway Activation on Ex Vivo Xenoperfusion Samples
IF staining was performed on ex vivo xenoperfusion biopsy samples for the deposition of MBL and its colocalization with IgM, C3b/c, C4b/c, and C6. In brief, 20-Km-thick sections were cut, fixed on slide, and treated with TBSTriton X-100 for 15 min. Deposition of MBL and its colocalization with complement proteins was assessed by using specific antibodies as mentioned above. Stained slides were observed using fluorescence microscopy (DMI 4000B; Leica, Wetzlar, Germany).
